Annual D&A
$3.27 M
+$879.00 K+36.81%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual depreciation & amortization is $3.27 million, with the most recent change of +$879.00 thousand (+36.81%) on December 31, 2023.
- During the last 3 years, ADCT annual D&A has risen by +$1.29 million (+65.67%).
- ADCT annual D&A is now at all-time high.
Performance
ADCT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$802.00 K
-$36.00 K-4.30%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly depreciation & amortization is $802.00 thousand, with the most recent change of -$36.00 thousand (-4.30%) on September 30, 2024.
- Over the past year, ADCT quarterly D&A has dropped by -$45.00 thousand (-5.31%).
- ADCT quarterly D&A is now -9.38% below its all-time high of $885.00 thousand, reached on September 30, 2023.
Performance
ADCT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.33 M
-$83.00 K-2.43%
September 30, 2024
Summary
- As of February 7, 2025, ADCT TTM depreciation & amortization is $3.33 million, with the most recent change of -$83.00 thousand (-2.43%) on September 30, 2024.
- Over the past year, ADCT TTM D&A has increased by +$63.00 thousand (+1.93%).
- ADCT TTM D&A is now -2.43% below its all-time high of $3.41 million, reached on June 30, 2024.
Performance
ADCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ADCT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.8% | -5.3% | +1.9% |
| 3 y3 years | +65.7% | +5.7% | +26.6% |
| 5 y5 years | +341.5% | +5.7% | +26.6% |
ADCT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.8% | -9.4% | +40.2% | -2.4% | +39.5% |
| 5 y | 5-year | at high | +98.5% | -9.4% | +83.5% | -2.4% | +651.7% |
| alltime | all time | at high | +858.1% | -9.4% | +83.5% | -2.4% | +651.7% |
ADC Therapeutics SA Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $802.00 K(-4.3%) | $3.33 M(-2.4%) |
| Jun 2024 | - | $838.00 K(-0.6%) | $3.41 M(+0.8%) |
| Mar 2024 | - | $843.00 K(-0.5%) | $3.39 M(+3.7%) |
| Dec 2023 | $3.27 M(+36.8%) | $847.00 K(-4.3%) | $3.27 M(+6.9%) |
| Sep 2023 | - | $885.00 K(+9.0%) | $3.06 M(+11.4%) |
| Jun 2023 | - | $812.00 K(+12.3%) | $2.74 M(+9.0%) |
| Mar 2023 | - | $723.00 K(+13.7%) | $2.52 M(+5.4%) |
| Dec 2022 | $2.39 M(-9.2%) | $636.00 K(+11.2%) | $2.39 M(-4.9%) |
| Sep 2022 | - | $572.00 K(-2.4%) | $2.51 M(-3.3%) |
| Jun 2022 | - | $586.00 K(-1.3%) | $2.60 M(-1.9%) |
| Mar 2022 | - | $594.00 K(-21.7%) | $2.65 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $2.63 M(+33.4%) | $759.00 K(+15.3%) | $2.63 M(+6.3%) |
| Sep 2021 | - | $658.00 K(+3.6%) | $2.47 M(+7.3%) |
| Jun 2021 | - | $635.00 K(+9.9%) | $2.31 M(+9.4%) |
| Mar 2021 | - | $578.00 K(-4.1%) | $2.11 M(+6.8%) |
| Dec 2020 | $1.97 M(+19.8%) | $603.00 K(+23.3%) | $1.97 M(+44.0%) |
| Sep 2020 | - | $489.00 K(+11.9%) | $1.37 M(+55.6%) |
| Jun 2020 | - | $437.00 K(-1.4%) | $880.00 K(+98.6%) |
| Mar 2020 | - | $443.00 K | $443.00 K |
| Dec 2019 | $1.65 M(+122.4%) | - | - |
| Dec 2018 | $740.00 K(+117.0%) | - | - |
| Dec 2017 | $341.00 K | - | - |
FAQ
- What is ADC Therapeutics SA annual depreciation & amortization?
- What is the all time high annual D&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual D&A year-on-year change?
- What is ADC Therapeutics SA quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly D&A year-on-year change?
- What is ADC Therapeutics SA TTM depreciation & amortization?
- What is the all time high TTM D&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM D&A year-on-year change?
What is ADC Therapeutics SA annual depreciation & amortization?
The current annual D&A of ADCT is $3.27 M
What is the all time high annual D&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual depreciation & amortization is $3.27 M
What is ADC Therapeutics SA annual D&A year-on-year change?
Over the past year, ADCT annual depreciation & amortization has changed by +$879.00 K (+36.81%)
What is ADC Therapeutics SA quarterly depreciation & amortization?
The current quarterly D&A of ADCT is $802.00 K
What is the all time high quarterly D&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly depreciation & amortization is $885.00 K
What is ADC Therapeutics SA quarterly D&A year-on-year change?
Over the past year, ADCT quarterly depreciation & amortization has changed by -$45.00 K (-5.31%)
What is ADC Therapeutics SA TTM depreciation & amortization?
The current TTM D&A of ADCT is $3.33 M
What is the all time high TTM D&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM depreciation & amortization is $3.41 M
What is ADC Therapeutics SA TTM D&A year-on-year change?
Over the past year, ADCT TTM depreciation & amortization has changed by +$63.00 K (+1.93%)